FP39
2219
Dr.Manjula Krishna
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 2219 | Dr.Manjula Krishna | drmanjula_k2007@yahoo.com | 9980160322 |
Medical Retina
Ocular Effects of GLP-1 Receptor Agonists: Benefits, Risks & Clinical Guidance
Purpose: To evaluate the ocular benefits and risks of GLP-1 receptor agonists (GLP-1 RAs) in diabetic patients. Methods: Literature review of 61 articles (2016-2026) from PubMed including meta-analyses, population studies, and case reports analyzing GLP-1 RA ocular effects. Results: GLP-1 RAs demonstrated protective effects: reduced diabetic retinopathy progression (8 studies, strong evidence), decreased neovascular AMD risk, glaucoma neuroprotection with IOP reduction, and improved ocular surface parameters. Mechanisms include anti-inflammatory, antioxidant, and neuroprotective pathways via retinal GLP-1 receptors. Risks identified: NAION association (6 case reports), rare vision impairment signals in FDA data. Semaglutide was most studied (12 articles). Conclusion: GLP-1 RAs offer significant ocular benefits for diabetic patients while requiring NAION vigilance. Baseline eye exams and symptom monitoring are recommended before and during therapy.
No Co-Author Selected